Katherine Fleshner1, Amy Tin1, Nicole Benfante1, Sigrid Carlsson1, Andrew J Vickers1. 1. Katherine Fleshner, University of Western Ontario, London, Ontario, Canada; Amy Tin, Nicole Benfante, Sigrid V. Carlsson, and Andrew J. Vickers, Memorial Sloan Kettering Cancer Center, New York, NY; and Sigrid V. Carlsson, Gothenburg University, Gothenburg, Sweden.
Abstract
PURPOSE: To determine whether patient-reported collection of comorbidities online is sufficiently accurate to warrant use as part of a physician-reviewed, baseline medical history. METHODS: Comorbidities were collected for a sample of 213 new prostate cancer visits to our urology clinic through an online survey (called Baseline Medical History) before the clinical encounter. The frequency distributions of comorbidities as reported by patients before physician review were compared with those documented by physicians for a sample of 298 consecutive patients presenting to the same urology clinic before the survey went live. RESULTS: The overall frequency distribution of comorbidities and life expectancy estimates were similar between the two groups. A few comorbidity categories were reported with higher frequency in the patient-reported group compared with the physician-documented group, including neurologic comorbidities (7.5% v 1.7%; difference 6%; 95% CI, 2.0% to 10%; P = .001) and back pain (24% v 13%; difference 12%; 95% CI, 4.8% to 19%; P = .001). A similar trend was seen for vascular conditions, although the difference did not meet conventional levels of statistical significance. Genitourinary comorbidities, including problems with urination and erectile dysfunction, were better captured by the physician-reported group compared with the patient-reported group (68% v 53%; difference 15%; 95% CI, 7% to 24%; P = .001), as were other musculoskeletal comorbidities (8.7% v 1.9%; difference 7%; 95% CI, 3.2% to 11%; P = .001). CONCLUSION: Patients completing a medical history, at their own pace and in the comfort of their own home, provide relatively accurate and complete information, even before physician review. Patient reporting of comorbidities thus seems to be a reliable starting point for the documentation of the medical history in the clinic.
PURPOSE: To determine whether patient-reported collection of comorbidities online is sufficiently accurate to warrant use as part of a physician-reviewed, baseline medical history. METHODS: Comorbidities were collected for a sample of 213 new prostate cancer visits to our urology clinic through an online survey (called Baseline Medical History) before the clinical encounter. The frequency distributions of comorbidities as reported by patients before physician review were compared with those documented by physicians for a sample of 298 consecutive patients presenting to the same urology clinic before the survey went live. RESULTS: The overall frequency distribution of comorbidities and life expectancy estimates were similar between the two groups. A few comorbidity categories were reported with higher frequency in the patient-reported group compared with the physician-documented group, including neurologic comorbidities (7.5% v 1.7%; difference 6%; 95% CI, 2.0% to 10%; P = .001) and back pain (24% v 13%; difference 12%; 95% CI, 4.8% to 19%; P = .001). A similar trend was seen for vascular conditions, although the difference did not meet conventional levels of statistical significance. Genitourinary comorbidities, including problems with urination and erectile dysfunction, were better captured by the physician-reported group compared with the patient-reported group (68% v 53%; difference 15%; 95% CI, 7% to 24%; P = .001), as were other musculoskeletal comorbidities (8.7% v 1.9%; difference 7%; 95% CI, 3.2% to 11%; P = .001). CONCLUSION:Patients completing a medical history, at their own pace and in the comfort of their own home, provide relatively accurate and complete information, even before physician review. Patient reporting of comorbidities thus seems to be a reliable starting point for the documentation of the medical history in the clinic.
Authors: Hyunsoon Cho; Angela B Mariotto; Bhupinder S Mann; Carrie N Klabunde; Eric J Feuer Journal: Am J Epidemiol Date: 2013-07-03 Impact factor: 4.897
Authors: Ethan Basch; David Artz; Alexia Iasonos; John Speakman; Kevin Shannon; Kai Lin; Charmaine Pun; Henry Yong; Paul Fearn; Allison Barz; Howard I Scher; Mary McCabe; Deborah Schrag Journal: J Am Med Inform Assoc Date: 2007-02-28 Impact factor: 4.497
Authors: Andrew J Vickers; Fernando J Bianco; Angel M Serio; James A Eastham; Deborah Schrag; Eric A Klein; Alwyn M Reuther; Michael W Kattan; J Edson Pontes; Peter T Scardino Journal: J Natl Cancer Inst Date: 2007-07-24 Impact factor: 13.506
Authors: Fan Ye; Dominic H Moon; William R Carpenter; Bryce B Reeve; Deborah S Usinger; Rebecca L Green; Kiayni Spearman; Nathan C Sheets; Kevin A Pearlstein; Angela R Lucero; Mark R Waddle; Paul A Godley; Ronald C Chen Journal: JAMA Oncol Date: 2017-08-01 Impact factor: 31.777
Authors: Erica H Lee; Rajiv I Nijhawan; Kishwer S Nehal; Stephen W Dusza; Amanda Levine; Amanda Hill; Christopher A Barker Journal: J Skin Cancer Date: 2015-06-09
Authors: Matthew Kent; David F Penson; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Janet L Stanford; Antoinette M Stroup; Behfar Ehdaie; Peter T Scardino; Andrew J Vickers Journal: BMC Med Date: 2016-02-09 Impact factor: 8.775
Authors: Patricia Mae G Santos; Andrew R Barsky; Wei-Ting Hwang; Curtiland Deville; Xingmei Wang; Stefan Both; Justin E Bekelman; John P Christodouleas; Neha Vapiwala Journal: Cancer Date: 2019-09-10 Impact factor: 6.860
Authors: Ryan Haggart; Elizabeth Polter; Michael Ross; Nidhi Kohli; Badrinath R Konety; Darryl Mitteldorf; William West; B R Simon Rosser Journal: Sex Med Date: 2021-10-08 Impact factor: 2.491
Authors: Daniel E Spratt; Neal Shore; Oliver Sartor; Dana Rathkopf; Kara Olivier Journal: Prostate Cancer Prostatic Dis Date: 2021-02-18 Impact factor: 5.554